Sentences with phrase «pharmaceutical stocks as»

Some examples of defensive sectors include utility, pipeline, pharmaceutical stocks as well as stocks with high dividend payouts.

Not exact matches

In 2015, Ackman, the founder of hedge fund Pershing Square, announced his multi-billion dollar bet on Valeant Pharmaceuticals (vrx); he proceeded to lose nearly his entire investment, or $ 7.7 million every day for about two years, as Valeant stock sank 95 %.

As news emerges of Amazon considering a big push into pharmaceuticals, CNBC's Jim Cramer endorsed one of his favorite drugmakers, Celgene, after its stock fell off a cliff on Thursday.

As pressure mounted over the pharmaceutical giant's rising insulin prices, investors drove its stock down by a third, fearing that policymakers would cap price tags and hurt profits.

Of course, other companies saw their stocks improve with the news, including pharmaceutical firms with Ebola vaccines such as Tekmira Pharmaceuticals (TKMR) and NewLink Genetics (NLNK), whose stocks soared.

Left, who has gained notoriety for successful bets against stocks such as Valeant Pharmaceuticals, explained that his rapid change of view on Twitter came as a result of the growing scrutiny surrounding social media and how companies handle users» personal information.

Teva Pharmaceuticals has proposed buying rival Mylan for $ 40 billion in cash and stock, as the Israel - based drugmaker looks to gain dominance among generic pharmaceutical companies.

For Canadians, owning some of these stocks will not only provide income but also diversification, as there are few domestic pharmaceutical stocks to choose from.

It's no secret we've been on the opposite side of Bill Ackman's Pershing Square Capital on many recent stock picks, such as Herbalife (HLF), Mondelez (MDLZ), and, most notably, Valeant Pharmaceuticals (VRX).

John also sits on the Board of Strongco Corp, traded on the Toronto Stock Exchange as SQP and DelMar Pharmaceuticals, which is traded on OTCQX as DMPI.

All told, we continue to view Merck & Co. stock as a solid core holding for investors seeking participation in the large pharmaceutical space.

An eight count fraud and conspiracy indictment also alleged he repaid the investors with stock and money improperly taken from Retrophin, a pharmaceutical company he previously served as chief executive.

As a heads up for this week, pharmaceutical stocks are set to be even more volatile than normal leading up to an...

He has also served as Delaware counsel for directors and board committees for such corporations as ABB, Ltd., Adelphia Communications Corporation, Airgas, Inc., Affiliated Computer Services, Inc., Alpha Natural Resources, Inc., AMF Holdings, Inc., Anheuser Busch Companies, Inc., Applied Materials, Inc., Ashworth, Inc., Bank of America Corporation, BarnesandNoble.com, Biosite, Inc., Cablevision Systems Corporation, Caterpillar, Inc., Citigroup, Inc., Clear Channel Outdoor Holdings, Inc., Coeur Mining, Inc., Computer Associates International, Inc., Cornerstone Therapeutics, Inc., Countrywide Financial Corporation, Countrywide Home Loans, Inc., Cysive, Inc., Danfoss A / S, Dreamworks Animation SKG, Duncan Energy Partners, E. I. du Pont de Nemours & Co., Inc., EON Labs, Inc., Epicor Software Corporation, Erickson Air Crane Inc., Fairfield Communities, Inc., FEDEX Corporation, First Franklin Financial Corporation, Fox & Hound Restaurant Group, FTI Consulting Inc., G.P. Strategies Inc., Gemstar International Group Ltd., Genencor International, Inc., Golden Telecom, Inc., Goldman Sachs, Google Inc., Health Management Associates, Inc., Hewlett - Packard Company, Hilton Worldwide Holdings, Inc., Houlihan's Restaurants, Inc., Huntsman Corporation, IGEN, Inc., ImClone Systems Incorporated, infoUSA, Inc., Insituform East, Inc., Intel Corporation, IntercontinentalExchange, Inc., iPass, Inc., Kenetech Corporation, Levi Strauss Associates, Inc., Liberty Media Corporation, Lifepoint Hospitals, Inc., Lorillard, Inc., Maytag Corporation, Micro General Corporation, Motorola, Inc., National Amusements, Inc. (majority stockholder of Viacom), National Steel Corporation, Net2Phone, News Corporation, NRG Energy, Inc., OEC Corporation, Online - City Search, Inc., PeopleSoft, Inc., Pharmacia Corporation, Phonefree.com, PLM International Inc., Printcafe Software, Inc., Pure Resources, Inc., Quest Software, Rent - A-Center, Inc., Rental Service Corporation, Republic Industries, Inc., Rockefeller Center Properties, Inc., Siliconix Incorporated, Simon Property Group Inc., Softbank Corp., Sotheby's, Space Imaging, Inc., Stock Building Supply Holdings, Inc., Suntory Holdings Limited, Take Two Interactive Software, Inc., Teppco Partners, L.P., The Hertz Corporation, The Talbots, Inc., Teva Pharmaceuticals USA, Inc., The Vanguard Group, Inc., The Walt Disney Company, TicketMaster, Todd A-O Corporation, Triad Hospitals, Inc., Unico Corporation, UTStarcom, Inc., Utz Quality Foods, Inc., Venoco, Inc., Veterinary Centers of America, Inc., VMWare, Inc., Walmart Stores, Inc., Walter Industries, Inc., Wheeling - Pittsburgh Corporation, Whistlepig, LLC, Wynn Resorts, Ltd., Zynga, Inc..

Sally Evans, a 61 - year - old pharmaceutical - industry sales analyst in the Chicago area, recalls her friends «bailing from the market,» even as she increased her retirement - account contributions and invested more aggressively in stocks.

Most utilities, packaged food and mature pharmaceutical companies possess characteristics often thought of as typical for value stocks: high free cash generation, high quality balance sheets and high dividend payouts.

Masimo, CVS Health, and Ligand Pharmaceuticals stand out as great healthcare stock picks for long...

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

Related healthcare stocks would fall, even crash, as pharmaceutical companies, and other healthcare - related stocks, along with junk food companies and those associated with Big Sugar, could burst.

The NASDAQ Biotechnology Index is a modified capitalization weighted index that includes NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical.

These are the funds / schemes which invest in the securities of only those sectors or industries as specified in the offer documents, e.g., Pharmaceuticals, Software, Fast Moving Consumer Goods (FMCG), Petroleum stocks, Information Technology (IT), Banks, etc..

The Slater Zulu Principle Screen throws up stocks such as Solid State, which manufactures specialist electronic components, Telford Homes and Telit Communications while the Buffettology-esque Historical Growth Screen points to stocks such as Avon Rubber, the engineering company, Shire, the pharmaceutical business and Magnit PAO, which operates convenience stores and hypermarkets in the Russian Federation.

With Valeant Pharmaceuticals, Ackman and other well - known value investors bought more Valeant stock as the company declined, increasing their losses.

Conversely, stable businesses like pharmaceuticals and high - dividend utilities stocks shed hardly any value, but never moved strongly as the economy improved — their sales were unaffected by slowdown or reversion.

The Agios Pharmaceuticals, Inc.'s extremely bullish / bearish sentiment could be considered as overbought / oversold condition when the AGIO stock is predisposed to a trend reversal.

For our recent report on a penny stock with big potential but a good deal of risk as well, read BioLine partners with leading pharmaceutical.

He previously served as a research analyst in the Equity division, where he covered life insurance stocks and specialty pharmaceuticals, generic pharmaceuticals, and drug wholesaler stocks.

Although the fund owns companies across the health care sector, including insurers and equipment makers, a pharmaceutical - heavy portfolio — about 60 % of Health Care's assets are invested in pharmaceutical and biotech firms — held the fund back over the past year as those stocks came under fire during the recent U.S. presidential campaign.

US firms cash in on active pharmaceutical sector as Valeant agrees deal to acquire Salix's outstanding stock

We acted, in conjunction with several international law firms, including our tie - up office, Addleshaw Goddard LLP, as a legal advisor for a UK - based, London Stock Exchange (AIM) listed company that is engaged worldwide in the business of pharmaceuticals in a transaction that could be worth as much as ￡ 100 million, where this company sought to acquire 100 % ownership of a globally oriented Singaporean company engaged in the distribution of highly specialized pharmaceutical and medical technology in Asia, Africa and Australia.

«We prefer software stocks among defensive sectors such as pharmaceuticals and IT, as they have entered a «buy zone» in terms of valuations after the...

Deeply committed in being a part of the pharmaceutical industry, I aspire to find a position as a pharmacist wherein my skills at dealing with customers, reading prescriptions, dispensing medications, managing stocks and handling cash books can be fully utilized.